ConductScience.org, home

Paper8690806

Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.

Fukaura H and 5 others. J Clin Invest, 1996. Cited by 351 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. Papers, record 8690806. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8690806

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
PubMed
Journal
J Clin Invest
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
351
iCite
Relative citation ratio, by iCite
7.35
iCite
Revised in PubMed
2022-03-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fukaura HH
2Kent SCS C
3Pietrusewicz MJM J
4Khoury SJS J
5Weiner HLH L
6Hafler DAD A

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AutoantigensMajor topic
Multiple SclerosisMajor topic
Myelin ProteinsMajor topic
T-Lymphocytes, Helper-InducerMajor topic
Transforming Growth Factor betaMajor topic
Administration, Oral
Clinical Trials as Topic
Follow-Up Studies
Humans
Immune Tolerance
Interferon-gamma
Interleukin-4
Myelin Basic Protein
Myelin Proteolipid Protein
Recurrence

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AR 43220NIAMS NIH HHSUnited StatesP01AR043220PubMed and NIHNIH RePORTER
R01-NS-29352NINDS NIH HHSUnited StatesR01NS029352PubMed and NIHNIH RePORTER
R01-NS24247NINDS NIH HHSUnited StatesR01NS024247PubMed and NIHNIH RePORTER

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
157,115Basis of microheterogeneity of myelin basic protein.J Biol Chem1976https://conductscience.org/library/papers/57115PubMed
28,820,272The expanding universe of T-cell subsets: Th1, Th2 and more.Immunol Today1996https://conductscience.org/library/papers/8820272PubMed
32,413,363T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.Nature1985https://conductscience.org/library/papers/2413363PubMed
43,463,976Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3463976PubMed
53,791,692Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats.Clin Exp Immunol1986https://conductscience.org/library/papers/3791692PubMed
62,447,178Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.J Immunol1988https://conductscience.org/library/papers/2447178PubMed
73,257,990Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice.J Immunol1988https://conductscience.org/library/papers/3257990PubMed
82,451,570Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.Cell Immunol1988https://conductscience.org/library/papers/2451570PubMed
92,478,145Inflammatory and immunomodulatory roles of TGF-beta.Immunol Today1989https://conductscience.org/library/papers/2478145PubMed
102,295,822Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures.J Immunol1990https://conductscience.org/library/papers/2295822PubMed
112,137,841Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.J Immunol1990https://conductscience.org/library/papers/2137841PubMed
122,120,332Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.J Immunol1990https://conductscience.org/library/papers/2120332PubMed
131,704,424Fatty acid composition of human myelin proteolipid protein in peroxisomal disorders.J Neurochem1991https://conductscience.org/library/papers/1704424PubMed
141,717,550Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.J Immunol1991https://conductscience.org/library/papers/1717550PubMed
151,717,632Antigen-driven bystander suppression after oral administration of antigens.J Exp Med1991https://conductscience.org/library/papers/1717632PubMed
161,946,445Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1946445PubMed
171,370,356
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1370356PubMed
181,377,368Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.Nature1992https://conductscience.org/library/papers/1377368PubMed
191,383,385
Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
J Exp Med1992https://conductscience.org/library/papers/1383385PubMed
207,680,493Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.Science1993https://conductscience.org/library/papers/7680493PubMed

See all 33 references

Cited by111

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 351 citations.

PMIDTitleJournalYearIn PapersSource
41,828,510AAV Gene Therapy for MPS IVA with Induction of Immune Tolerance via Oral Administration of Epitope Peptides of N-Acetylgalactosamine-6-sulfate Sulfatase.Int J Mol Sci2026https://conductscience.org/library/papers/41828510PubMed
39,362,875Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39362875PubMed
37,900,596Bibliometric analysis of global research trends on regulatory T cells in neurological diseases.Front Neurol2023https://conductscience.org/library/papers/37900596PubMed
37,283,612Recombinant MBP-pσ1 expressed in soybean seeds delays onset and reduces developing disease in an animal model of multiple sclerosis.Plant Biotechnol (Tokyo)2022https://conductscience.org/library/papers/37283612PubMed
36,289,525Concanavalin A as a promising lectin-based anti-cancer agent: the molecular mechanisms and therapeutic potential.Cell Commun Signal2022https://conductscience.org/library/papers/36289525PubMed
35,919,740Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity.Immunother Adv2021https://conductscience.org/library/papers/35919740PubMed
35,919,733Oral tolerance as antigen-specific immunotherapy.Immunother Adv2021https://conductscience.org/library/papers/35919733PubMed
35,087,799Electrical Stimulation for Immune Modulation in Cancer Treatments.Front Bioeng Biotechnol2021https://conductscience.org/library/papers/35087799PubMed
35,003,073Role of Exercise Intensity on Th1/Th2 Immune Modulations During the COVID-19 Pandemic.Front Immunol2021https://conductscience.org/library/papers/35003073PubMed
33,679,769Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future.Front Immunol2021https://conductscience.org/library/papers/33679769PubMed
33,248,367Role of orally induced regulatory T cells in immunotherapy and tolerance.Cell Immunol2021https://conductscience.org/library/papers/33248367PubMed
32,617,181Atheroprotective nasal immunization with a heat shock protein 60 peptide from Porphyromonas gingivalis.J Periodontal Implant Sci2020https://conductscience.org/library/papers/32617181PubMed
31,758,298Molecular characterization and immune protection of an AN1-like zinc finger protein of Eimeria tenella.Parasitol Res2020https://conductscience.org/library/papers/31758298PubMed
31,134,056The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer.Front Immunol2019https://conductscience.org/library/papers/31134056PubMed
30,531,969PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs.Nat Commun2018https://conductscience.org/library/papers/30531969PubMed
30,082,532Immune Tolerance Therapy: A New Method for Treatment of Traumatic Brain Injury.Chin Med J (Engl)2018https://conductscience.org/library/papers/30082532PubMed
29,491,358To respond or not to respond - a personal perspective of intestinal tolerance.Nat Rev Immunol2018https://conductscience.org/library/papers/29491358PubMed
28,454,277Monocyte-derived dendritic cells from patients with cervical intraepithelial lesions.Oncol Lett2017https://conductscience.org/library/papers/28454277PubMed
27,417,020Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis.J Allergy Clin Immunol2017https://conductscience.org/library/papers/27417020PubMed
27,154,631Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.Clin Immunol2016https://conductscience.org/library/papers/27154631PubMed

See all 111 cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNG3,458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL43,565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene
MBP4,155PubTator's text mininghttps://conductscience.org/library/genes/4155NCBI Gene
PLP15,354PubTator's text mininghttps://conductscience.org/library/genes/5354NCBI Gene
TGFB17,040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8690806

GET https://conductscience.org/api/papers/v1/8690806/references?page=2